HF
BIVI icon

HRT Financial’s BioVie BIVI Stock Holding History

HRT Financial’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32K Buy
+23,482
New +$30.2K ﹤0.01% 3515
2025
Q2 		– Sell
-1,090
Closed -$10K – 2630
2025
Q1 		$10K Buy
+1,090
New +$17.4K ﹤0.01% 2352
2023
Q2 		– Sell
-172
Closed -$139K – 2483
2023
Q1 		$139K Buy
+172
New +$114K ﹤0.01% 1999
2022
Q4 		– Sell
-176
Closed -$43K – 2479
2022
Q3 		$43K Buy
+176
New +$41.9K ﹤0.01% 2452

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial's BIVI Position: Q1 2026 in Review

HRT Financial opened a new position in BioVie (BIVI) in Q1 2026: 23,482 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #3515 among its holdings. This is a return to the name: HRT Financial previously reported a position in BIVI as recently as Q1 2025.

HRT Financial first reported a position in BIVI in Q3 2022 and has held it in 4 quarters since. The position peaked at $139K in Q1 2023. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • HRT Financial held 23,482 shares of BioVie worth $32K as of Q1 2026.
  • BioVie was a new HRT Financial position in Q1 2026.
  • BioVie made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3515 holding.
  • HRT Financial first reported a position in BioVie in Q3 2022 and has held it in 4 quarters since.
  • HRT Financial's BioVie position peaked at $139K in Q1 2023.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.